Acetylcholinesterase inhibitors considerably affect the salivary microbiome in patients with Alzheimer’s disease

Acetylcholinesterase inhibitors considerably affect the salivary microbiome in patients with Alzheimer’s disease

Summary: Microbiome alterations are reportedly linked to systemic disease progression and medication. However, the effects of central nervous system drugs on the microbiome of patients with neurodegenerative diseases, such as Alzheimer’s or Parkinson’s disease, are poorly understood. Here, we compre...

Full description

Saved in:
Bibliographic Details
Main Authors: Daisuke Hisamatsu, Hiroaki Masuoka, Haruka Takeshige-Amano, Rina Kurokawa, Yusuke Ogata, Wataru Suda, Taku Hatano, Daisuke Asaoka, Yo Mabuchi, Yuna Naraoka, Nobuhiro Sato, Takashi Asada, Nobutaka Hattori, Masahira Hattori, Chihiro Akazawa
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:iScience
Subjects:
Health sciences
Medicine
Medical specialty
Psychiatry
Internal medicine
Neurology
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004225008545
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2589004225008545

Similar Items